Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Rothman

Showing results (91-100 of 159) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2002
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonistBryan L Roth, Karen Baner, Richard Westkaemper, et al.
Synapse (New York, N.Y.)|March 14, 2002
Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout miceRichard B Rothman, F Ivy Carroll, Marisela Morales, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2014
Alpha-ethyltryptamines as dual dopamine-serotonin releasersBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Journal of Medicinal Chemistry|September 29, 2012
14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsSubramaniam Ananthan, Surendra K Saini, Christina M Dersch, et al.
Journal of Medicinal Chemistry|January 21, 2011
Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphansKejun Cheng, Yong Sok Lee, Richard B Rothman, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypesAndrea L Pelotte, Ryan M Smith, Mario Ayestas, et al.
Journal of Medicinal Chemistry|July 25, 2009
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphansYi Zhang, Yong Sok Lee, Richard B Rothman, et al.
Psychopharmacology|October 21, 2018
The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomesBruce E Blough, Ann M Decker, Antonio Landavazo, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeuticsBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Bioorganic & Medicinal Chemistry|August 2, 2002
Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphanAkihiro Hashimoto, Arthur E Jacobson, Richard B Rothman, et al.
Pageof 16

Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2002
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonistBryan L Roth, Karen Baner, Richard Westkaemper, et al.
Synapse (New York, N.Y.)|March 14, 2002
Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout miceRichard B Rothman, F Ivy Carroll, Marisela Morales, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2014
Alpha-ethyltryptamines as dual dopamine-serotonin releasersBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Journal of Medicinal Chemistry|September 29, 2012
14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsSubramaniam Ananthan, Surendra K Saini, Christina M Dersch, et al.
Journal of Medicinal Chemistry|January 21, 2011
Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphansKejun Cheng, Yong Sok Lee, Richard B Rothman, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypesAndrea L Pelotte, Ryan M Smith, Mario Ayestas, et al.
Journal of Medicinal Chemistry|July 25, 2009
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphansYi Zhang, Yong Sok Lee, Richard B Rothman, et al.
Psychopharmacology|October 21, 2018
The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomesBruce E Blough, Ann M Decker, Antonio Landavazo, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeuticsBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Bioorganic & Medicinal Chemistry|August 2, 2002
Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphanAkihiro Hashimoto, Arthur E Jacobson, Richard B Rothman, et al.
Pageof 16